Table 4.

Association between Serum Biomarker Concentrations and Cardiac Dimensions as Measured by Cardiac Magnetic Resonance Imaging, Adjusted for Age at Diagnosis, Time Since Diagnosis, Race, and Ethnicity^*†

	Log of %LGE			Log of LV Mass (BSA-adjusted)			Log of LV Mass/ LVEDV			Log of LV Mass / LVESV			Log Interventricular Septal Thickness
Serum Biomarker	N	β (SE)	P- value	N	β (SE)	P- value	N	β (S E)	P- value	N	β (S E)	P- value	N	β (S E)	P- value
NT-proBN p, pg/mL	44	0.09(0.09)	0.31	4 8	0.20(0.03)	<0.001	47	0.21(0.03)	<0.001	47(0.04)	0.16	0.001	5 9	0.19(0.02)	<0.001
Cardiac troponi n-T, ng/mL	44	0.03(0.20)	0.90	48	0.18(0.09)	0.05	47	0.12(0.09)	0.21	47	0.13(0.11)	0.22	59	0.03(0.08)	0.69

Abbreviations: LGE, late gadolinium enhancement; LV, left ventricle; BSA, body surface area; NT-proBNP, N-terminalpro B-type natriuretic peptide.

^*Four patients with 0% LGE of LV mass were excluded because zero cannot be log-transformed.

^†Four patients with LAMP2 mutations were excluded from the association analysis.